How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life

Gilead Sciences (NASDAQ: GILD) and Novartis (NYSE: NVS) have enormous resources to acquire, develop, and market some miraculous new cancer therapies, but selling these treatments has been a lot tougher than expected.

Hold on to your seat because the Centers for Medicare and Medicaid Services (CMS) recently released 1,800 pages of proposed rule changes.